We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Lung Cancer Survivors Receive Too Many PET Scans

By MedImaging International staff writers
Posted on 08 Mar 2016
Print article
Lung and esophageal cancer survivors undergo excessive positron emission tomography (PET) scans during follow-up care with no impact on survival, claims a new study.

Researchers at the University of Michigan (U-M; Ann Arbor, USA), and Dartmouth-Hitchcock Medical Center (Lebanon, NH, USA) searched the US Surveillance, Epidemiology, and End Results (SEER) register to identify 97,152 primary lung and 4,446 esophageal cancer patients with follow-up data, using patient and tumor characteristics to calculate risk-adjusted two-year overall survival. Using Medicare claims, they then examined PET utilization in person-years, excluding scans for staging and for follow-up of CT findings, and stratified hospitals by quintiles of PET utilization for adjusted two-year survival analysis.

The results showed a statistically significant variation in utilization of PET scans, ranging from 0.05 to 0.70 scans per person-year for lung cancer and 0.12 to 0.97 scans per person-year for esophageal cancer. But despite the statistically significant variation in use of PET to detect tumor recurrence, there was no association with improved two-year survival, suggesting possible overuse of PET for recurrence detection, which current Medicare policy would not appear to substantially affect. The study was published on February 22, 2016, in the Journal of the National Cancer Institute.

“PET scanning is a great technology and very effective, but using it in this way doesn't seem to make any difference for these cancers that have a relatively poor prognosis,” said lead author Mark Healy, MD, of U-M. “Following evidence-based guidelines for clinical follow-up is the way to go; don't order PET in asymptomatic patients. And for patients, if you are not having symptoms and you're doing well, there's no reason to seek out this scan.”

PET scans are often used for staging, restaging, and monitoring of cancer patients for treatment response. They are also often used to detect recurrence in asymptomatic patients, despite a lack of evidence demonstrating improved survival. The US Centers for Medicare & Medicaid Services (CMS; Baltimore, MD, USA) impose a limit of three follow-up PET scans per person, even when doctors only order them following a computerized tomography (CT) or other medical imaging procedure.

Related Links:

University of Michigan
Dartmouth-Hitchcock Medical Center
The US Centers for Medicare & Medicaid Services


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Illuminator
Trimline Basic
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
New
X-Ray Detector
FDR-D-EVO III

Print article

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.